What stage does Thuja Capital invest at?

Thuja Capital invests at the Seed, Series A, Series B stages.

What sectors does Thuja Capital focus on?

Thuja Capital focuses on Biotech, Medical Devices.

Where is Thuja Capital located?

Thuja Capital is headquartered in Utrecht, NL.

Thuja Capital

Venture capital

Utrecht · Seed–Series B · 7 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Thuja Capital invests in early-stage biotechnology and medical device companies. The firm focuses on healthcare and life science innovations.

Invests inBiotech Medical Devices Belgium Europe Netherlands Utrecht

Stage

Seed–Series B

Utrecht, NL

Instruments

Equity

Founded

2006

AUM

$135M

Tracked investments

Team · 7 people

from public directories

Evan Castiglia· Partner

e•••@thujacapital.comreveal

Michel Briejer· Managing Partner

m•••@thujacapital.comreveal

Tyler Hayes· Principal· Earthin 𝕏

Tyler Hayes is Co-Founder and CEO of Atom, an artificial bodies company developing AI-powered prosthetics, including the Atom Touch prosthetic arm. Previously, he was a cofounder of second-generation Bebo, a startup studio that created products including an esports tournament platform, and founded Prime, a health coordination app that enabled families to access medical records from thousands of clinics and hospitals. He was also an early employee at Disqus, the networked comments platform, where he led Product and Community teams.

t•••@thujacapital.comreveal

Eline van Beest· Venture Partner

e•••@thujacapital.comreveal

Florian Ludwig· Venture Partner

f•••@thujacapital.comreveal

Eleanor Price· Associate

e•••@thujacapital.comreveal

Lisanne Blauw· Associate

l•••@thujacapital.comreveal

What they invest in

from 4 of 4 portfolio companies

Biotech ×4Healthtech ×3Deep Tech ×2Medical Devices ×2

HQs:Germany×1Netherlands×1

Investments · 4 tracked

founders shown can be your intro path

Artica Therapeuticsartica-tx.com in✓ verified

Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach.

BiotechDeep TechHealthtech

Tjeerd Barf(Co-founder & CEO)Arwin Ridder(Co-founder & COO)Ad IJzerman(Co-founder & SAB Chair)Jason(Chief Scientific Officer)

Co-investorsBioGeneration Ventures Seroba Life Sciences

ATROatromedical.com in✓ verified

ATRO Medical is a Dutch clinical-stage orthopedic company developing the Artimis artificial meniscus implant (prosthesis) for patients with chronic knee pain after meniscectomy.

BiotechHealthtechMedical DevicesNijmegen, NL

Tony van Tienen(Founder)

Co-investorsBOM

Tacalyxtacalyx.com✓ verified

Tacalyx develops novel anticancer therapeutics that target Tumor-Associated Carbohydrate Antigens (TACAs), including antibody-drug conjugate programs.

BiotechDeep TechMedical DevicesBerlin, DE

Peter Seeberger(Co-founder (Prof. Dr.))Oren Moscovitz(CSO & Co-founder)

Co-investorsCreathor Ventures Kurma Partners Boehringer Ingelheim Venture Fund coparion

Alestaalestatherapeutics.com in

Alesta Therapeutics is a biotech company developing oral small molecule therapies for rare diseases with limited treatment options.

BiotechHealthtech

Co-investorsDroia Ventures Frazier Life Sciences Novartis Venture Fund Frazier Healthcare Partners RTW Investments L.P.

Portfolio news

latest coverage across their companies

Etched's $21b valuation, Smack's battlefield software, and Goldman's real estate buy

Alesta · axios.com · Aug 18, 2026

Frequently asked questions

What stage does Thuja Capital invest at?: Thuja Capital invests at the Seed, Series A, Series B stages.
What sectors does Thuja Capital focus on?: Thuja Capital focuses on Biotech, Medical Devices.
Where is Thuja Capital located?: Thuja Capital is headquartered in Utrecht, NL.

Similar investors

Capricorn Venture Partners

Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.

$270K – $10.8M

Sofinnova Ventures

Sofinnova is an investment firm that partners with biotech companies from inception through growth, supporting drug development, the regulatory process, company building, and IPO.

$100K – $15M

Kaiser Permanente Ventures

Kaiser Permanente Ventures is the corporate venture capital arm investing in healthcare companies that address real needs and deliver value for patients, providers, healthcare delivery systems, and communities.

$2M – $5M

Foresite Capital

Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.

Korea Investment Partners

Korea Investment Partners is a South Korea-based venture capital firm that invests across multiple stages from early-stage startups through growth and buyout transactions, including venture debt and mezzanine financing. The firm operates across venture capital, middle market, and growth equity investment categories.

$973K – $50M